Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.
The call bell light in room 12-204 was the first to go off at the crack of dawn, breaking the serene silence of the floor. “I need to shower so I can see the race!” the patient exclaimed.
E. David Crawford, MD, professor of radiation oncology University of Colorado Denver, discusses the potential side effects of frequently used prostate cancer treatments.
Norman E. Sharpless, MD, Professor of Medicine & Genetics Chair, The Lineberger Comprehensive Cancer Center, discusses a recent study that evaluated sunscreen’s effectiveness in reducing melanoma risk.
Patients who receive certain cancer treatments are at greater risk of secondary malignancies and must be educated accordingly.
Bridgett Harr of the Cleveland Clinic Cancer Center explains what survivorship might look like for patients with head and neck cancer.
Hyoung Jin Kang, MD, PhD, associate professor, Department of Pediatrics, Seoul National University, South Korea, discusses a phase III trial of aprepitant for chemotherapy-induced nausea and vomiting (CINV) in children.
The risk for pancreatic cancer dramatically decreases the longer a person takes low-dose aspirin
Older patients with diffuse large B-cell lymphoma (DLBCL) often have an increased risk of treatment-related morbidity and mortality, but the use of preventive interventions, such as granulocyte colony-stimulating factor (G-CSF) may help.
With new immune checkpoint inhibitors being utilized in treating patients with ICC, physicians need to study new ways to address irAEs associated with this treatment.
The number of cancer survivors in the United States has quadrupled since 1971, making it imperative for healthcare professionals to identify and address the needs of this burgeoning population.
Alex Herrera discusses the response of patients with Hodgkin lymphoma on combination nivolumab/brentuximab vedotin.
Carol Blecher, MS, RN, AOCN, Trinitas Comprehensive Cancer Center, discusses using exercise not only as rehabilitation for patients with cancer, but also “prehabilitation”.
L. Stewart Massad, MD, discusses recent updates to guidelines for cervical cancer screening intended to implement prevention strategies that are less intrusive and reduce morbidity.
Michael L. Krychman, MD, Executive Director of the Southern California Center for Sexual Health and Survivorship Medicine, discusses managing and treating sexual health concerns in cancer patients and survivors.
Christopher R. Friese, PhD, RN, AOCN, FAAN, assistant professor, Division of System Leadership and Effectiveness Science, University of Michigan School of Nursing, discusses the National Institute for Occupational Safety and Health (NIOSH) $2.3 million research grant that will be used to identify exposure risks.
Frank delaRama, RN, MS, AOCNS®, from the Palo Alto Medical Foundation, explains the role of oncology nurse navigators in providing relevant information to men with prostate cancer.
Celestia Higao, MD, talks about the difficulty of discussing sexual health, particularly with male patients.
Financial toxicity can have an impact on patients' anxiety and depression, but oncology nurses can help.
Using mobile apps and other new technologies, clinicians can better monitor and help their patients.
As a social worker, I have come to understand the different ways patients redefine hope, gratitude, and spirituality after being diagnosed with cancer.
Recommended treatment regimens for patients with renal cell carcinoma (RCC) continue to change as novel therapies and combinations are approved by the FDA.
Patricia Geddie, MS, CNS, AOCNS, a clinical nurse specialist at Orlando Health, discusses a study looking at family caregiver knowledge.
Erica Fischer-Cartlidge MSN, CNS, CBCN, AOCNS, compares the efficacy magic mouthwash and preventive steps for oral mucositis.
It is widely accepted that the single greatest risk factor for cancer is age. Sixty percent of cancers and two-thirds of cancer deaths occur over the age of 65 years.
No one likes going to the dentist, but l'm thankful I did.
Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, talks about the role rare cancer research has in advancing cancer care as a whole.